immunomodulators
Showing 26 - 50 of 245
Atopic Dermatitis Eczema Trial in London (Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment, Placebo TLA Device)
Recruiting
- Atopic Dermatitis Eczema
- Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment
- Placebo TLA Device
-
London, United KingdomIMPERIAL COLLEGE HEALTHCARE NHS Trust
Sep 22, 2022
Azathioprine Linked With Impaired Intestinal Epithelial
Completed
- Inflammatory Bowel Diseases
- (no location specified)
Jul 11, 2022
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)
Enrolling by invitation
- Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Obinutuzumab
- +6 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Mar 22, 2023
Systemic Lupus Erythematosus Trial in Worldwide (Placebo, Nipocalimab, Standard-of-care treatment)
Recruiting
- Systemic Lupus Erythematosus
- Placebo
- +2 more
-
Los Alamitos, California
- +101 more
Aug 4, 2022
IBD Trial in Chicago (Evening Group, Morning Group)
Active, not recruiting
- Inflammatory Bowel Diseases
- Evening Group
- Morning Group
-
Chicago, IllinoisRush University Medical Center
Sep 22, 2022
Relapsed/Refractory Multiple Myeloma Trial in Australia, United States (ISB 1442 SC injection escalating doses, ISB 1442 SC
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 1442 SC injection escalating doses
- ISB 1442 SC injection at RP2D
-
New York, New York
- +5 more
Jun 17, 2022
Ulcerative Colitis Trial in Wuhan (Fecal Microbiota Transplantation)
Recruiting
- Ulcerative Colitis
- Fecal Microbiota Transplantation
-
Wuhan, ChinaTongji Hospital
Jan 30, 2023
Acute Pancreatitis Trial (Micro-encapsulated granules of tributyrin (intervention), Micro-encapsulated granules of sunflower oil
Not yet recruiting
- Acute Pancreatitis
- Micro-encapsulated granules of tributyrin (intervention)
- Micro-encapsulated granules of sunflower oil (placebo)
- (no location specified)
Nov 24, 2023
Colorectal Cancer Trial in China (Huaier granule)
Not yet recruiting
- Colorectal Cancer
- Huaier granule
-
Harbin, Heilongjiang, China
- +8 more
Oct 15, 2023
CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)
Active, not recruiting
- CD55-deficient Protein-losing Enteropathy
- CHAPLE
-
Bethesda, Maryland
- +2 more
Nov 8, 2022
National GMA Post-market Clinical Follow-up Study (GRACE)
Recruiting
- Crohn Disease
- Ulcerative Colitis
- Adacolumn
-
Badalona, Barcelona, Spain
- +28 more
Nov 24, 2022
A Multicenter, Prospective, Long-term, Observational Registry of
Active, not recruiting
- Crohn's Disease
- +3 more
- Anti TNF therapy including infliximab
- No Biologics
-
Mobile, Alabama
- +61 more
Jan 31, 2023
Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)
Recruiting
- Bendamustine
- Multiple Myeloma
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Aug 7, 2021
Patients With Inflammatory Bowel Diseases
Active, not recruiting
- IBD
- Covid19
- Covid-19 vaccine
-
Petah Tikva, IsraelRabin Medical Center
Oct 3, 2021
Coronavirus Infection Trial in Brooklyn (Colchicine, Usual Care)
Terminated
- Coronavirus Infection
- Colchicine
- Usual Care
-
Brooklyn, New YorkMaimonides Medical Center
Feb 16, 2022
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Rozibafusp Alfa, Placebo for Rozibafusp Alfa)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- Rozibafusp Alfa
- Placebo for Rozibafusp Alfa
-
Birmingham, Alabama
- +146 more
Feb 1, 2023
Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -
Not yet recruiting
- Crohn Disease
- TNFa Antagonist - Infliximab
- +5 more
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 22, 2023
Copeptin in COVID-19
Completed
- COVID-19
- Assessement of serum copeptin by ELISA technique
-
Cairo, EgyptAl-Zahraa Hospital, Al-Azhar University, Cairo, Egypt
Feb 18, 2022
Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)
Recruiting
- Lymphoma
- +3 more
- Isatuximab
- Standard Procedures
-
New York, New YorkColumbia University
Apr 27, 2022
Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)
Completed
- Idiopathic Pulmonary Fibrosis
-
Athens, Greece
- +6 more
Nov 17, 2021
Lichen Sclerosus Trial in Herne (Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser)
Recruiting
- Lichen Sclerosus
- Clobetasol 0.05% Emollient Top Cream
- Non-ablative CO2 Laser
-
Herne, NRW, GermanyMarien Hospital Herne
Nov 3, 2021
Nutrition, Healthy Trial in Medellín (Yeast ß-glucan fiber, Placebo)
Active, not recruiting
- Nutrition, Healthy
- Yeast β-glucan fiber
- Placebo
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 4, 2022
Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)
Suspended
- Melanoma (Skin)
- Melanoma in Situ
- Aldesleukin
- Saline
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II Health Sciences Centre
Jul 18, 2022
COVID-19 Vaccine in Autoimmune and Inflammatory Diseases Treated
Terminated
- Autoimmune Diseases
- Inflammatory Disorder
- Blood sample
-
Paris, FranceInternal medicine Service - Cochin Hospital
Dec 7, 2022